Immunotherapy for Alzheimer's disease: enlightenment to neurodegenerative diseases

Immunotherapy for Alzheimer's disease: enlightenment to neurodegenerative diseases

doi: 10.3969/j.issn.1672-6731.2014.04.002

Bibliographic Details
Main Author:	Ying ZHANG
Format:	Article
Language:	English
Published:	Tianjin Huanhu Hospital 2014-04-01
Series:	Chinese Journal of Contemporary Neurology and Neurosurgery
Subjects:	Alzheimer disease Immune system Aging Biological markers Immunotherapy Review
Online Access:	http://www.cjcnn.org/index.php/cjcnn/article/view/926

Similar Items

Recent advances in Alzheimer's disease all over the world
by: Yin-hua WANG, et al.
Published: (2015-07-01)

Immunotherapy for Alzheimer’s Disease: Past, Present and Future
by: Brian eSpencer, et al.
Published: (2014-06-01)

Cerebrospinal fluid biomarkers in early diagnosis of Alzheimer's disease
by: Jun WANG, et al.
Published: (2014-04-01)

Application of pattern classification in the diagnosis of Alzheimer's disease
by: Min-yue CHI, et al.
Published: (2015-07-01)

The Functional Roles and Applications of Immunoglobulins in Neurodegenerative Disease
by: Kyu-Young Sim, et al.
Published: (2020-07-01)

Immunotherapies for Neurodegenerative Diseases
by: Ibrahim Mortada, et al.
Published: (2021-06-01)

Editorial: Immunological Mechanisms, Biomarkers and Immunotherapies of Alzheimer's Disease
by: Jia-yan Xin, et al.
Published: (2021-09-01)

The situations and strategies of amyloid⁃β⁃directed passive immunotherapy for Alzheimer's disease
by: Ya LI, et al.
Published: (2019-12-01)

Antibody Engineering for Optimized Immunotherapy in Alzheimer's Disease
by: Isabelle L. Sumner, et al.
Published: (2018-04-01)

Immunotherapy for the treatment of Alzheimer's disease: amyloid-β or tau, which is the right target?
by: Castillo-Carranza DL, et al.
Published: (2013-12-01)

The progress of cerebrospinal fluid biomarkers in patients with neurodegenerative diseases
by: Li-li YANG, et al.
Published: (2013-02-01)

Single-Chain Fragment Variable Passive Immunotherapies for Neurodegenerative Diseases
by: Liang Huang, et al.
Published: (2013-09-01)

The age of enlightenment in melanoma immunotherapy
by: Mark R. Albertini
Published: (2018-08-01)

Chronic peripheral inflammation: a possible contributor to neurodegenerative diseases
by: Patrick Süβ, et al.
Published: (2021-01-01)

Peripheral biomarkers of oxidative stress in aging and Alzheimer's disease
by: Tania Marcourakis, et al.

The biological pathways of Alzheimer disease: a review
by: Marco Calabrò, et al.
Published: (2021-01-01)

Novel immunological approaches for the treatment of Alzheimer's disease
by: Priyanka Sabharwal, et al.
Published: (2014-03-01)

Investigation of expression of Alzheimer disease related genes in peripheral blood and their diagnostic implications.
Published: (2010)

FUNDAMANT: an interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimer’s disease
by: Petr Novak, et al.
Published: (2018-10-01)

Progress in clinical studies of dementia in 2013
by: Yu-lei DENG, et al.
Published: (2014-04-01)

Research progress in early diagnosis of Alzheimer's disease
by: Meng-sha SUN, et al.
Published: (2018-03-01)

Anti-amyloid-beta to tau-based immunization: developments in immunotherapy for Alzheimer's disease
by: Lambracht-Washington D, et al.
Published: (2013-08-01)

Mitophagy in Alzheimer’s Disease and Other Age-Related Neurodegenerative Diseases
by: Qian Cai, et al.
Published: (2020-01-01)

Role of Ketogenic Diets in Neurodegenerative Diseases (Alzheimer’s Disease and Parkinson’s Disease)
by: Dariusz Włodarek
Published: (2019-01-01)

The role of butyrylcholinesterase in the pathogenesis of Alzheimer's disease
by: Hao WU, et al.
Published: (2017-12-01)

Novel Microbial-Based Immunotherapy Approach for Crohn's Disease
by: Simon Sutcliffe, et al.
Published: (2019-07-01)

Alzheimer’s disease and immunotherapy: what is wrong with clinical trials?
by: Kohyama K, et al.
Published: (2015-01-01)

Neurodegenerative diseases as proteinopathies-driven immune disorders
by: Fausta Ciccocioppo, et al.
Published: (2020-01-01)

Peripheral immune system in aging and Alzheimer’s disease
by: Wei Cao, et al.
Published: (2018-10-01)

Microglial motility in Alzheimer’s disease and after Aβ42 immunotherapy: a human post-mortem study
by: Diana K. Franco-Bocanegra, et al.
Published: (2019-11-01)

Differential Associations of IL-4 With Hippocampal Subfields in Mild Cognitive Impairment and Alzheimer’s Disease
by: Virginia Boccardi, et al.
Published: (2019-01-01)

The Therapeutic Potential of Metformin in Neurodegenerative Diseases
by: Carola Rotermund, et al.
Published: (2018-07-01)

Dynamics of Dynamin-Related Protein 1 in Alzheimer’s Disease and Other Neurodegenerative Diseases
by: Darryll Oliver, et al.
Published: (2019-08-01)

Passive immunotherapy rapidly increases structural plasticity in a mouse model of Alzheimer disease
by: Tara L. Spires-Jones, et al.
Published: (2009-02-01)

Microglia Phenotypes Converge in Aging and Neurodegenerative Disease
by: Michael Candlish, et al.
Published: (2021-05-01)

Parental Age and the Risk for Alzheimer’s Disease in Offspring: Systematic Review and Meta-Analysis
by: Natalia Szejko, et al.
Published: (2021-06-01)

Nutrition Patterns in Prevention and Treatment of Neurodegenerative Diseases: Alzheimer’s Disease
by: Vesna Šeper, et al.
Published: (2019-05-01)

Use of C. elegans as a Model to Study Alzheimer’s Disease and Other Neurodegenerative Diseases
by: Adanna G Alexander, et al.
Published: (2014-09-01)

The presubiculum is preserved from neurodegenerative changes in Alzheimer’s disease
by: Christina E. Murray, et al.
Published: (2018-07-01)

Genetic targeting of astrocytes to combat neurodegenerative disease
by: Rachel Kery, et al.
Published: (2020-01-01)

Cannot write session to /tmp/vufind_sessions/sess_26lsjsf9qp8fhm633m7h1ckoeh